From the Blogs: How to Make Preventing Heart Disease in HIV Fun and Exciting: The REPRIEVE Trial

February 15, 2017

From the Blogs: How to Make Preventing Heart Disease in HIV Fun and Exciting: The REPRIEVE Trial

Dr. Paul Sax talks about how to make heart disease prevention in HIV “fun and exciting” in HIV and ID Observations.

People with HIV appear to have a higher risk for heart disease. In the latest HIV and ID Observations blog post, Dr. Paul Sax discusses the REPRIEVE trial, which asks if patients with HIV would benefit from taking a statin even if they are not ordinarily prescribed.

Want to see more from NEJM Journal Watch? Register here.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.